CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS Impact factor 2025

---

The latest impact factor of CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS and all the other Web of Science journals was released on 20th June 2025 by Clarivate. Through this web page, researchers can check the impact factor, total citation, journal quartile, and journal aim & scope.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS: Aim & Scope

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS is a Web of Science indexed journal tha publishes research in the area: Oncology | Medicine, Research & Experimental | Pharmacology & Pharmacy | Radiology, Nuclear Medicine & Medical Imaging.
The ISSN of this journal is 15578852.

Impact factor of CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Journal Title	Cancer Biotherapy and Radiopharmaceuticals
Impact Factor	2.4
SJR	0.65
ISSN	15578852
Quartile	Q2

Impact Factor from year 2018-2024

Year	Impact Factor
2018	1.682
2019	1.894
2020	2.314
2021	3.099
2022
2023	3.4
2025	2.4

The Journal Impact Factor is defined as citations to the journal in the JCR year to items published in the previous two years, divided by the total number of scholarly items, also known as citable items, (these comprise articles and reviews) published in the journal in the previous two years.

Impact factor data has a strong influence on the scientific community, affecting decisions on where to publish, whom to promote or hire, the success of grant applications, and even salary bonuses.

Only journals listed in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI) receive an Impact Factor.

Similiar journals to publish

---

Cancer Biotherapy and Radiopharmaceuticals

ISSN: 15578852
Journal Impact: 2.4
Journal Scope: Oncology | Medicine, Research & Experimental | Pharmacology & Pharmacy | Radiology, Nuclear Medicine & Medical Imaging

Cancer Biotherapy & Radiopharmaceuticals

ISSN: 1557-8852
Journal Impact:
Journal Scope:

Chinese Journal of Cancer Biotherapy

ISSN: 1007385X
Journal Impact:
Journal Scope: Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)

Journal of Labelled Compounds and Radiopharmaceuticals

ISSN: 10991344
Journal Impact:
Journal Scope: Analytical Chemistry (Q2); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)

Current Radiopharmaceuticals

ISSN: 18744729
Journal Impact: 1.5
Journal Scope: Pharmacology & Pharmacy | Radiology, Nuclear Medicine & Medical Imaging

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

ISSN: 1099-1344
Journal Impact: 0.9
Journal Scope: Biochemical Research Methods | Chemistry, Medicinal | Chemistry, Analytical

Cancer Research and Treatment : Official Journal of Korean Cancer Association

ISSN: 2005-9256
Journal Impact:
Journal Scope:

Cancer Control : Journal of the Moffitt Cancer Center

ISSN: 1526-2359
Journal Impact:
Journal Scope:

Blood and Lymphatic Cancer: Targets and Therapy

ISSN: 1179-9889
Journal Impact:
Journal Scope: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs

BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY

ISSN: 1179-9889
Journal Impact: 3.9
Journal Scope: Oncology

About SCI

SCI is a multidisciplinary citation index. Science Citation Index covers 9,000+ journals across 177 scientific disciplines. SCI was established in 1900 to the current. SCI-indexed journals are indexed by SCI and SSCI. SCI is described as the world's leading journal.

All journals covered in this database are reviewed for sufficiently high quality each year.

How to publish in SCI journals?